Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the previous year. The Net Loss for the business is ₹16.04 Crore from the profit of ₹50.80 Crore year on year. Earnings per Share is -₹0.98 for this quarter.
Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%
Tags: pharmaceuticals
Related Post
- Titan Company Ltd Q2FY25; 1.5% fall in Net Profits
Company Overview: Titan Company Ltd is among India’s most respected lifestyle companies. It has established…
-
Coal India Ltd Q2FY25; 22% fall in Profits
Coal India Ltd is mainly engaged in mining and production of Coal and also operates…
-
Cholamandalam Investment & Finance Company Ltd Q2FY25; 25% rise in Profits
Cholamandalam Investment & Finance Company is one of the premier diversified non-banking finance companies in…